These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
580 related articles for article (PubMed ID: 25625286)
1. Prevalence and global initiative for chronic obstructive lung disease group distribution of chronic obstructive pulmonary disease detected by preoperative pulmonary function test. Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG PLoS One; 2015; 10(1):e0115787. PubMed ID: 25625286 [TBL] [Abstract][Full Text] [Related]
2. Impact of GOLD groups of chronic pulmonary obstructive disease on surgical complications. Kim HJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Kim YW; Han SK; Choi SM Int J Chron Obstruct Pulmon Dis; 2016; 11():281-7. PubMed ID: 26929613 [TBL] [Abstract][Full Text] [Related]
3. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study. Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748 [TBL] [Abstract][Full Text] [Related]
4. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease]. Sleszycka J; Woźniak K; Banaszek M; Wiechno W; Domagała-Kulawik J Pol Merkur Lekarski; 2009 Aug; 27(158):92-6. PubMed ID: 19856871 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of colorectal adenomatous polyps in patients with chronic obstructive pulmonary disease. Chun EM; Kim SW; Lim SY Int J Chron Obstruct Pulmon Dis; 2015; 10():955-60. PubMed ID: 26028968 [TBL] [Abstract][Full Text] [Related]
6. Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study. Bárbara C; Rodrigues F; Dias H; Cardoso J; Almeida J; Matos MJ; Simão P; Santos M; Ferreira JR; Gaspar M; Gnatiuc L; Burney P Rev Port Pneumol; 2013; 19(3):96-105. PubMed ID: 23664024 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013. Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708 [TBL] [Abstract][Full Text] [Related]
8. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity. Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587 [TBL] [Abstract][Full Text] [Related]
9. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing? Kjeldgaard P; Dahl R; Løkke A; Ulrik CS Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573 [TBL] [Abstract][Full Text] [Related]
10. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients. Kawamatawong T; Onnipa J; Suwatanapongched T Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of chronic obstructive pulmonary disease among adult male cigarettes smokers: a community-based study in Jordan. Al Omari M; Khassawneh BY; Khader Y; Dauod AS; Bergus G Int J Chron Obstruct Pulmon Dis; 2014; 9():753-8. PubMed ID: 25092972 [TBL] [Abstract][Full Text] [Related]
12. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Shirtcliffe P; Marsh S; Travers J; Weatherall M; Beasley R Intern Med J; 2012 Jan; 42(1):83-8. PubMed ID: 20403069 [TBL] [Abstract][Full Text] [Related]
13. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands. Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067 [TBL] [Abstract][Full Text] [Related]
14. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity? Echave-Sustaeta JM; Comeche Casanova L; Cosio BG; Soler-Cataluña JJ; Garcia-Lujan R; Ribera X Int J Chron Obstruct Pulmon Dis; 2014; 9():1307-14. PubMed ID: 25429213 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies. Sansores RH; Ramírez-Venegas A; Hernández-Zenteno R; Mayar-Maya ME; Pérez-Bautista OG; Velázquez Uncal M Respir Med; 2013 Apr; 107(4):580-6. PubMed ID: 23313037 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population. Zhang J; Zhou JB; Lin XF; Wang Q; Bai CX; Hong QY Respirology; 2013 Feb; 18(2):297-302. PubMed ID: 23051099 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a claims-based prediction model for COPD severity. Macaulay D; Sun SX; Sorg RA; Yan SY; De G; Wu EQ; Simonelli PF Respir Med; 2013 Oct; 107(10):1568-77. PubMed ID: 23806285 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Lindberg A; Jonsson AC; Rönmark E; Lundgren R; Larsson LG; Lundbäck B Respiration; 2005; 72(5):471-9. PubMed ID: 16210885 [TBL] [Abstract][Full Text] [Related]
19. Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease. Al-Kassimi FA; Abba AA; Al-Hajjaj MS; Alhamad EH; Raddaoui E; Shaikh SA Respiration; 2011; 82(1):19-27. PubMed ID: 21282939 [TBL] [Abstract][Full Text] [Related]
20. Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice. Hernández M; García G; Falco J; García AR; Martín V; Ibarrola M; Quadrelli S Int J Chron Obstruct Pulmon Dis; 2018; 13():351-356. PubMed ID: 29403272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]